Press releases

Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting

Disclosure of transparency notification

Disclosure of transparncy notification

ANNOUNCEMENT REGARDING ENFORCEMENT BY SECURED CREDITORS

Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio

Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit

Disclosure of transparency notification

Agreement regarding recapitalization of operating subsidiaries by secured creditors and wind down of listed holding company

Biocartis announces H1 2023 Results and provides an update on the operational reorganization an recapitalization

Biocartis 2023 Half-Year Results Webcast on 26 September 2023